Recent experiments have shown that oleanolic acid, a new drug that can be used to treat osteoporosis, inhibits RANKL-induced osteoclastogenesis through the ERα/miR-503/RANK signaling pathway in RAW264.7 cells [85]. Here, TNFSF11 is linked to osteoporosis.